The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer.
Open accessAbstract
Heparan sulfate proteoglycans (HSPGs) play diverse roles in cell recognition, growth, and adhesion. In vitro studies suggest that cell-surface HSPGs act as coreceptors for heparin-binding mitogenic growth factors. Here we show that the glycosylphosphatidylinositol- (GPI-) anchored HSPG glypican-1 is strongly expressed in human pancreatic cancer, both by the cancer cells and the adjacent fibroblasts, whereas expression of glypican-1 is low in the normal pancreas and in chronic pancreatitis. Treatment of two pancreatic cancer cell lines, which express glypican-1, with the enzyme phosphoinositide-specific phospholipase-C (PI-PLC) abrogated their mitogenic responses to two heparin-binding growth factors that are commonly overexpressed in pancreatic cancer: fibroblast growth factor 2 (FGF2) and heparin-binding EGF-like growth factor (HB-EGF). PI-PLC did not alter the response to the non-heparin-binding growth factors EGF and IGF-1. Stable expression of a form of glypican-1 engineered to possess a transmembrane domain instead of a GPI anchor conferred resistance to the inhibitory effects of PI-PLC on growth factor responsiveness. Furthermore, transfection of a glypican-1 antisense construct attenuated glypican-1 protein levels and the mitogenic response to FGF2 and HB-EGF. We propose that glypican-1 plays an essential role in the responses of pancreatic cancer cells to certain mitogenic stimuli, that it is relatively unique in relation to other HSPGs, and that its expression by pancreatic cancer cells may be of importance in the pathobiology of this disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yayon, A., Klagsbrun, M., Esko, J. D., Leder, P., & Ornitz, D. M. (1991) · Cell · doi:10.1016/0092-8674(91)90512-w · Cited by 2,440
Requirement of Heparan Sulfate for bFGF-Mediated Fibroblast Growth and Myoblast Differentiation
Rapraeger, A. C., Krufka, A., & Olwin, B. B. (1991) · Science · doi:10.1126/science.1646484 · Cited by 1,508
Warshaw, A. L., & Castillo, C. F.-D. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202133260706 · Cited by 1,198
Biology of the Syndecans: A Family of Transmembrane Heparan Sulfate Proteoglycans
Bernfield, M., Kokenyesi, R., Kato, M., Hinkes, M. T., Spring, J., Gallo, R. L., & Lose, E. J. (1992) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.08.110192.002053 · Cited by 1,097
Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome
Pilia, G., Hughes-Benzie, R. M., MacKenzie, A., Baybayan, P., Chen, E. Y., Huber, R., Neri, G., Cao, A., Forabosco, A., & Schlessinger, D. (1996) · Nature Genetics · doi:10.1038/ng0396-241 · Cited by 761
Spivak-Kroizman, T., Lemmon, M. A., Dikic, I., Ladbury, J. E., Pinchasi, D., Huang, J., Jaye, M., Crumley, G., Schlessinger, J., & Lax, I. (1994) · Cell · doi:10.1016/0092-8674(94)90032-9 · Cited by 658
Ornitz, D. M., Yayon, A., Flanagan, J. G., Svahn, C. M., Levi, E., & Leder, P. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.1.240 · Cited by 632
Saksela, O., & Rifkin, D. B. (1990) · The Journal of cell biology · doi:10.1083/jcb.110.3.767 · Cited by 539
Korc, M., Chandrasekar, B., Yamanaka, Y., Friess, H., Buchier, M., & Beger, H. G. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116001 · Cited by 492
Self-citationSchlessinger, J., Lax, I., & Lemmon, M. (1995) · Cell · doi:10.1016/0092-8674(95)90112-4 · Cited by 465
Integral membrane heparan sulfate proteoglycans
David, G. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.11.8370471 · Cited by 418
The type 1 (EGFR-related) family of growth factor receptors and their ligands
Prigent, S. A., & Lemoine, N. R. (1992) · Progress in Growth Factor Research · doi:10.1016/0955-2235(92)90002-y · Cited by 369
Yamanaka, Y., Frieß, H., Büchler, M. W., Beger, H. G., Uchida, E., Onda, M., Kobrin, M. S., & Korc, M. (1993) · PubMed · Cited by 354
Self-citationHeparin-Binding EGF-Like Growth Factor
National Cancer Institute (2020) · Definitions · doi:10.32388/hz52we · Cited by 345
Reichsman, F., Smith, L., & Cumberledge, S. (1996) · The Journal of cell biology · doi:10.1083/jcb.135.3.819 · Cited by 305
Rapraeger, A., Jalkanen, M., Endo, E., Koda, J., & Bernfield, M. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39146-9 · Cited by 304
David, G., Lories, V, Decock, B., Marynen, P., Cassiman, J. J., & Van den Berghe, H. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.6.3165 · Cited by 288
Vlodavsky, I., Miao, H.-Q., Medalion, B., Danagher, P., & Ron, D. (1996) · Cancer and Metastasis Reviews · doi:10.1007/bf00437470 · Cited by 286
Roghani, M., Mansukhani, A., Dell'Era, P., Bellosta, P., Basilico, C., Rifkin, D. B., & Moscatelli, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41730-3 · Cited by 261
Nakato, H., Futch, T. A., & Selleck, S. B. (1995) · Development · doi:10.1242/dev.121.11.3687 · Cited by 259
Herndon, M. E., & Lander, A. D. (1990) · Neuron · doi:10.1016/0896-6273(90)90148-9 · Cited by 245
Self-citationPantoliano, M. W., Horlick, R. A., Springer, B. A., Van Dyk, D. E., Tobery, T., Wetmore, D. R., Lear, J. D., Nahapetian, A. T., Bradley, J. D., & Sisk, W. P. (1994) · Biochemistry · doi:10.1021/bi00200a003 · Cited by 238
Olwin, B. B., & Rapraeger, A. (1992) · The Journal of cell biology · doi:10.1083/jcb.118.3.631 · Cited by 238
Heparin-binding EGF-like growth factor
Raab, G., & Klagsbrun, M. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00024-3 · Cited by 189
Stipp, C., Litwack, E., & Lander, A. (1994) · The Journal of cell biology · doi:10.1083/jcb.124.1.149 · Cited by 183
Self-citationInki, P., Joensuu, H., Grénman, R., Klemi, P., & Jalkanen, M. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.300 · Cited by 166
Induction and expression of amphiregulin in human pancreatic cancer.
Ebert, M. P., Yokoyama, M., Kobrin, M. S., Friess, H., Lopez, M. E., Büchler, M. W., Johnson, G. R., & Korc, M. (1994) · PubMed · Cited by 156
Self-citationWatanabe, K., Yamada, H., & Yamaguchi, Y. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.130.5.1207 · Cited by 155
Saunders, S., Paine‐Saunders, S., & Lander, A. D. (1997) · Developmental Biology · doi:10.1006/dbio.1997.8690 · Cited by 133
Self-citationHeparan sulfate proteoglycan expression in human lung-cancer cells
Nackaerts, K. L., Verbeken, E. K., Deneffe, G. J., Vanderschueren, B., Demedts, M., & David, G. (1997) · International Journal of Cancer · Cited by 126
Expression of the heparan sulfate proteoglycan glypican-1 in the developing rodent
Litwack, E. D., Ivins, J. K., Kumbasar, A., Paine‐Saunders, S., Stipp, C. S., & Lander, A. D. (1998) · Developmental Dynamics · Cited by 125
Self-citationHeparin Binding and Oligomerization of Hepatocyte Growth Factor/Scatter Factor Isoforms
Sakata, H., Stahl, S. J., Taylor, W. G., Rosenberg, J. M., Sakaguchi, K., Wingfield, P. T., & Rubin, J. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.14.9457 · Cited by 125
Binding of heparan sulfate to type V collagen
LeBaron, R. G., Höök, A., Esko, J. D., Gay, S., & Höök, M. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83134-9 · Cited by 124
Induction and Expression of Heparin-Binding EGF-Like Growth Factor in Human Pancreatic Cancer
Kobrin, M. S., Funatomi, H., Friess, H., et al. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2131 · Cited by 121
Self-citationIsolation of a cDNA Corresponding to a Developmentally Regulated Transcript in Rat Intestine
Filmus, J., Church, J. G., & Buick, R. N. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.10.4243-4249.1988 · Cited by 115
Bonneh‐Barkay, D., Shlissel, M., Berman, B., Shaoul, E., Admon, A., Vlodavsky, I., Carey, D. J., Asundi, V. K., Reich‐Slotky, R., & Ron, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.19.12415 · Cited by 113
Heparan Sulfate-mediated Cell Aggregation
Stanley, M. J., Liebersbach, B. F., Liu, W., Anhalt, D. J., & Sanderson, R. D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5077 · Cited by 112
[11] Regulation by heparan sulfate in fibroblast growth factor signaling
Rapraeger, A. C., Guimond, S. E., Krufka, A., & Olwin, B. B. (1994) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(94)45013-7 · Cited by 105
Kornmann, M., Ishiwata, T., Beger, H. G., et al. (1997) · Oncogene · doi:10.1038/sj.onc.1201307 · Cited by 100
Self-citationLitwack, E. D., Stipp, C. S., Kumbasar, A., & Lander, A. D. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-06-03713.1994 · Cited by 93
Self-citationHeparan sulfate proteoglycans are required for mesoderm formation in Xenopus embryos
Itoh, K., & Sokol, S. Y. (1994) · Development · doi:10.1242/dev.120.9.2703 · Cited by 89
A rapid quantitative assay for the detection of mammalian heparanase activity
Freeman, C. G., & Parish, C. R. (1997) · Biochemical Journal · doi:10.1042/bj3250229 · Cited by 84
Arreaza, G., & Brown, D. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23641 · Cited by 78
Lander, A. D., Stipp, C. S., & Ivins, J. K. (1996) · PubMed · Cited by 72
Self-citationIvins, J. K., Litwack, E. D., Kumbasar, A., Stipp, C. S., & Lander, A. D. (1997) · Developmental Biology · doi:10.1006/dbio.1997.8532 · Cited by 70
Self-citationGrowth Inhibition of Human Pancreatic Carcinoma Cells by Transforming Growth Factor Beta-1
Baldwin, R. L., & Korc, M. (1993) · Growth Factors · doi:10.3109/08977199309029131 · Cited by 65
Self-citationCarey, D. J., & Evans, D. M. (1989) · The Journal of Cell Biology · doi:10.1083/jcb.108.5.1891 · Cited by 64
Lindsay, S., Ireland, M., O’Brien, O., Clayton‐Smith, J., Hurst, J. A., Mann, J., Cole, T. J., Sampson, J., Slaney, S. F., Schlessinger, D., et al. (1997) · Journal of Medical Genetics · doi:10.1136/jmg.34.6.480 · Cited by 64
cDNA Cloning, Genomic Organization, and in Vivo Expression of Rat N-syndecan
Carey, D. J., Conner, K. J., Asundi, V. K., O’Mahony, D. J., Stahl, R. C., Showalter, L., Cizmeci-Smith, G., Hartman, J. J., & Rothblum, L. I. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.5.2873 · Cited by 63
Tumor necrosis factor up-regulates gamma-interferon binding in a human carcinoma cell line.
Raitano, A., & Korc, M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)86970-8 · Cited by 55
Self-citationDelehedde, M., Deudon, E., Boilly, B., et al. (1996) · Experimental Cell Research · doi:10.1006/excr.1996.0385 · Cited by 53
Chiang, M., & Flanagan, J. G. (1995) · Growth Factors · doi:10.3109/08977199509003208 · Cited by 50
Biology of the Syndecans: A Family of Transmembrane Heparan Sulfate Proteoglycans
Bernfield, M. R. (1992) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.8.1.365 · Cited by 45
Production of heparanase by normal and neoplastic murine B‐lymphocytes
Laskov, R., Ishai-Michaeli, R., Sharir, H., Yefenof, E., & Vlodavsky, I. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910470117 · Cited by 33
Asundi, V. K., Keister, B. F., Stahl, R. C., & Carey, D. J. (1997) · Experimental Cell Research · doi:10.1006/excr.1996.3400 · Cited by 33
Lévy, P., Munier, A., Baron-Delage, S., Gioia, Y. D., Gespach, C. P., Capeau, J., & Cherqui, G. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.376 · Cited by 22
Fukuda, K., Inui, Y., Kawata, S., Higashiyama, S., Matsuda, Y., Maeda, Y., Igura, T., Yoshida, S., Taniguchi, N., & Matsuzawa, Y. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.10.1680 · Cited by 20
Potential markers (enzymes, proteoglycans) for human liver tumors.
Kovalszky, I., Schaff, Z., & Jéney, A. (1993) · PubMed · Cited by 12
The cell surface proteoglycan syndecan-1 mediates fibroblast growth factor-2 binding and activity
Filla, M. S., Dam, P., & Rapraeger, A. C. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199803)174:3<310::aid-jcp5>3.0.co;2-r
Cited by
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
Melo, S. A., Luecke, L. B., Kahlert, C., Fernandez, A. F., Gammon, S. T., Kaye, J., LeBleu, V. S., Mittendorf, E. A., Weitz, J., Rahbari, N., et al. (2015) · Nature · doi:10.1038/nature14581 · Cited by 2,880
Kleeff, J., Korc, M., Apte, M., La Vecchia, C., Johnson, C. D., Biankin, A. V., Neale, R. E., Tempero, M., Tuveson, D. A., Hruban, R. H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.22 · Cited by 1,982
Self-citationGenetics and biology of pancreatic ductal adenocarcinoma
Hezel, A. F., Kimmelman, A. C., Stanger, B. Z., Bardeesy, N., & DePinho, R. A. (2006) · Genes & Development · doi:10.1101/gad.1415606 · Cited by 1,577
Extracellular vesicles in cancer — implications for future improvements in cancer care
Xu, R., Rai, A., Chen, M., Suwakulsiri, W., Greening, D. W., & Simpson, R. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0036-9 · Cited by 1,445
The sweet and sour of cancer: glycans as novel therapeutic targets
Fuster, M. M., & Esko, J. D. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1649 · Cited by 1,383
Metadata
- Authors
- Kleeff, J., Ishiwata, T., Kumbasar, A., Friess, H., Büchler, M. W., Lander, A. D., & Korc, M.
- Venue
- Journal of Clinical Investigation
- Published
- 1998-11-01
- Volume
- 102
- Issue
- 9
- Pages
- 1662-1673
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2014463647
- Cited by
- 368
- References
- 59
- FWCI
- 4.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.